Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Shares Outstanding for 2 consecutive years, with $62.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 4.54% to $62.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $62.1 million, a 4.54% increase, with the full-year FY2024 number at $60.0 million, changed N/A from a year prior.
  • Shares Outstanding was $62.1 million for Q3 2025 at Pyxis Oncology, roughly flat from $62.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $62.1 million in Q3 2025 to a low of $58.8 million in Q1 2024.